labiotech1d
Monoclonal antibodies: are they the key to treating Alzheimer’s disease?
Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...
Can a Drug Prevent Alzheimer’s Disease Decades Before It Happens?
Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.
Monoclonal Antibodies: A New Era In Alzheimer's Treatment
Monoclonal antibodies have emerged as a promising approach in the fight against Alzheimer's disease, offering hope for slowing its progression. T ...
News Medical on MSN5d
A new way to detect inflammation using antibodies developed
Nearly every disease has an inflammatory component, but blood tests can't pinpoint inflammation in specific organs or tissues ...
FiercePharma1d
Eisai execs flag Leqembi 'expansion phase' on the horizon as Alzheimer's med grows slowly
Some two years into Leqembi’s launch, Eisai continues to go all-in on its Alzheimer’s disease-fighting antibody, which the ...
News Medical on MSN8d
International Alzheimer’s prevention trial in young adults begins
The first participants in an international clinical trial aimed at preventing Alzheimer’s disease in young adults at high ...
Medscape12d
EMA to Review New Safety Data on Alzheimer’s Drug Leqembi
The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.
news.stv2d
Alzheimer’s drug decision branded ‘heartbreaking setback’ for sufferers
The Scottish Medicines Consortium announced lecanemab would not be made available on the NHS, following a similar decision ...
PMLiVE5d
International Alzheimer’s disease prevention trial in at-risk young adults begins
An international clinical trial aimed at preventing Alzheimer’s disease (AD) in young adults who are at risk of developing ...